ARCHIVES

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

This article is from The Cancer Letter archive.

Vol. 09 No. 42 | November 4, 1983

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

Advocacy: Friends To Continue Another Year

June 13, 1997

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980